CannTrust Holdings Inc. ("CannTrust" or the "Company" | CSE: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation ("ACMPR") program, is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to list its common shares on the TSX.
Aphria increases revenue 39% and Kilograms(1) sold 45% in quarter Canada NewsWire
Ninth consecutive quarter of positive adjusted EBITDA from operations(2)
Announced capacity run rate in early 2019 in excess of 200,000 kgs
Provides leading supply position in early stages of expected under supplied adult-use market
Canadian licensed medical marijuana producers recorded mixed movements yesterday and the sector came well off its highs in the morning.
We are monitoring this volatility as it comes while several firms have announced or completed significant financing agreements. Capital continues to enter the Canadian cannabis industry and we do not expect this trend to end anytime soon.
- Fagron to utilize its existing international distribution network to market and distribute CanniMed medicinal cannabis products to 17 specified countries with aggregate population of over 760 million
- Primary initial focus on Germany
- Germany fully legalized medicinal cannabis in March 2017
DOJA Cannabis Company Limited (CSE: DOJA) is pleased to announce the closing of its previously announced non-brokered private placement of subscription receipts whereby Aphria Inc. (TSX:APH and US OTC: APHQF) and Koicha Partners LP acquired from DOJA an aggregate of 8,992,807 Subscription Receipts of the Company at a price per Subscription Receipt of $1.39 for gross proceeds of $12,500,001.73.